Biogen Inc

NASDAQ:BIIB USA Drug Manufacturers - General
Market Cap
$26.89 Billion
Market Cap Rank
#748 Global
#591 in USA
Share Price
$183.26
Change (1 day)
+0.94%
52-Week Range
$113.38 - $201.18
All Time High
$414.71
About

Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; SKYCLARYS to treat Friedreich's Ataxia; QALSODY for treating amyotrophic lateral sclerosis; FUMADERM to treat plaque psorias… Read more

Biogen Inc (BIIB) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of December 2025: 0.028x

Based on the latest financial reports, Biogen Inc (BIIB) has a cash flow conversion efficiency ratio of 0.028x as of December 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($511.90 Million) by net assets ($18.26 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Biogen Inc - Cash Flow Conversion Efficiency Trend (1989–2025)

This chart illustrates how Biogen Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Biogen Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biogen Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Biogen Inc (1989–2025)

The table below shows the annual cash flow conversion efficiency of Biogen Inc from 1989 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $18.26 Billion $2.20 Billion 0.121x -29.80%
2024-12-31 $16.72 Billion $2.88 Billion 0.172x +64.54%
2023-12-31 $14.80 Billion $1.55 Billion 0.105x +1.11%
2022-12-31 $13.39 Billion $1.38 Billion 0.103x -68.87%
2021-12-31 $10.96 Billion $3.64 Billion 0.332x -16.09%
2020-12-31 $10.69 Billion $4.23 Billion 0.396x -25.41%
2019-12-31 $13.34 Billion $7.08 Billion 0.531x +11.76%
2018-12-31 $13.03 Billion $6.19 Billion 0.475x +31.44%
2017-12-31 $12.60 Billion $4.55 Billion 0.361x -3.12%
2016-12-31 $12.13 Billion $4.52 Billion 0.373x -5.93%
2015-12-31 $9.37 Billion $3.72 Billion 0.396x +45.70%
2014-12-31 $10.81 Billion $2.94 Billion 0.272x +0.01%
2013-12-31 $8.62 Billion $2.35 Billion 0.272x +0.77%
2012-12-31 $6.96 Billion $1.88 Billion 0.270x +0.42%
2011-12-31 $6.43 Billion $1.73 Billion 0.269x -9.83%
2010-12-31 $5.45 Billion $1.62 Billion 0.298x +73.68%
2009-12-31 $6.26 Billion $1.07 Billion 0.172x -36.30%
2008-12-31 $5.81 Billion $1.56 Billion 0.269x +46.11%
2007-12-31 $5.53 Billion $1.02 Billion 0.184x +56.74%
2006-12-31 $7.15 Billion $841.27 Million 0.118x -8.65%
2005-12-31 $6.91 Billion $889.50 Million 0.129x +20.78%
2004-12-31 $6.83 Billion $727.99 Million 0.107x +243.13%
2003-12-31 $7.05 Billion $219.21 Million 0.031x -81.43%
2002-12-31 $1.60 Billion $267.08 Million 0.167x -28.63%
2001-12-31 $1.35 Billion $316.36 Million 0.235x -29.09%
2000-12-31 $1.11 Billion $365.94 Million 0.331x +18.98%
1999-12-31 $979.53 Million $272.29 Million 0.278x +19.01%
1998-12-31 $718.61 Million $167.84 Million 0.234x +28.30%
1997-12-31 $536.29 Million $97.63 Million 0.182x +89.47%
1996-12-31 $484.37 Million $46.54 Million 0.096x +289.43%
1995-12-31 $382.98 Million $9.45 Million 0.025x -76.67%
1994-12-31 $329.93 Million $34.89 Million 0.106x -27.76%
1993-12-31 $325.20 Million $47.60 Million 0.146x -3.21%
1992-12-31 $285.00 Million $43.10 Million 0.151x +512.60%
1991-12-31 $239.00 Million $5.90 Million 0.025x -66.39%
1990-12-31 $145.70 Million $10.70 Million 0.073x +236.30%
1989-12-31 $139.20 Million $-7.50 Million -0.054x --